Our service capability involves working collaboratively with our customers to develop protocols and processes to produce bespoke differentiated cells and tissues for their specific application. Where the customer has a fully developed protocol we are the outsource partner that ensures they have a reliable supply of cells that integrate with their in-house drug screening or toxicity testing or disease modelling projects.

Projects can include tissue sourcing, reprogramming and differentiation to ensure consistency and control across the supply chain. We work with academic and industry teams with the aim of allowing them to focus on the next discovery knowing that they have a quality and consistent source of hiPSC derived cells on demand.

If you have an enquiry about a potential collaboration, please complete and submit the form below.

By clicking “Submit” I agree to Newcells Biotech¬†Privacy Policy.